Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.
Falkenhain-López D, Muniesa C, Estrach MT, Morillo-Andújar M, Peñate Y, Acebo E, Pujol RM, García-Muret MP, Machan S, Medina S, Botella-Estrada R, Fernández de Misa R, Blanes M, Flórez A, Pérez-Paredes G, Izu R, Yanguas I, Silva-Díaz E, Pérez-Ferriols A, Prieto-Torres L, Zayas A, Parera-Amer ME, Pérez A, Aspe L, Román C, Sánchez-Caminero MP, Bassas-Vila J, Domínguez-Auñón JD, Calzado L, Navedo M, Ortiz-Prieto A, Servitje O, Polo-Rodríguez I, Torres I, Hernández-Hernández MN, Mitxelena-Eceiza J, García-Vázquez A, García-Doval I, Ortiz-Romero PL. Falkenhain-López D, et al. Among authors: yanguas i. Actas Dermosifiliogr. 2023 Apr;114(4):291-298. doi: 10.1016/j.ad.2022.11.010. Epub 2022 Dec 15. Actas Dermosifiliogr. 2023. PMID: 36529273 Free article. English, Spanish.
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. Sánchez-Díaz M, et al. Among authors: yanguas i. Actas Dermosifiliogr. 2024 Mar;115(3):237-245. doi: 10.1016/j.ad.2023.10.016. Epub 2023 Oct 26. Actas Dermosifiliogr. 2024. PMID: 37890617 Free article. English, Spanish.
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, Carrascosa-Carrillo JM. Sánchez-Díaz M, et al. Among authors: yanguas i. Actas Dermosifiliogr. 2024 Mar;115(3):T237-T245. doi: 10.1016/j.ad.2024.01.019. Epub 2024 Jan 17. Actas Dermosifiliogr. 2024. PMID: 38242435 Free article. English, Spanish.
Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumab.
Gracia Cazaña T, Riera Monroig J, Izu R, Yanguas I, Lorda Espés M, Sánchez Salas MP, García Gil MF, Navarro Bielsa A, Aldea Manrique B, Almenara Blasco M, García-Latasa de Araníbar FJ, Fuentelsaz V, Morales Callaghan A, Ara-Martín M. Gracia Cazaña T, et al. Among authors: yanguas i. JAAD Int. 2024 Apr 7;16:66-71. doi: 10.1016/j.jdin.2024.02.019. eCollection 2024 Sep. JAAD Int. 2024. PMID: 38774344 Free PMC article.
Allergic Contact Dermatitis to Polycrylene®.
Agulló A, Oscoz S, Larrea M, Hervella M, Yanguas I. Agulló A, et al. Among authors: yanguas i. Indian J Dermatol. 2022 May-Jun;67(3):315. doi: 10.4103/ijd.IJD_52_17. Indian J Dermatol. 2022. PMID: 36386115 Free PMC article. No abstract available.
Correction to: Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non‑sentinel node status: retrospective cohort study with long follow‑up in a Spanish population.
Loidi-Pascual L, Librero J, Córdoba-Iturriagagoitia A, Guarch-Troyas R, Montes-Díaz M, Ruiz de Azua-Ciria Y, Arozarena I, Goñi-Gironés E, Yanguas I. Loidi-Pascual L, et al. Among authors: yanguas i. Arch Dermatol Res. 2022 May;314(4):379. doi: 10.1007/s00403-021-02302-2. Arch Dermatol Res. 2022. PMID: 34812922 No abstract available.
Sentinel node tumor burden in cutaneous melanoma. Survival with competing risk analysis and influence in relapses and non-sentinel node status: retrospective cohort study with long follow-up in a Spanish population.
Loidi-Pascual L, Librero J, Córdoba-Iturriagagoitia A, Guarch-Troyas R, Montes-Díaz M, Ruiz de Azua-Ciria Y, Arozarena I, Goñi-Gironés E, Yanguas I. Loidi-Pascual L, et al. Among authors: yanguas i. Arch Dermatol Res. 2022 May;314(4):369-378. doi: 10.1007/s00403-021-02232-z. Epub 2021 May 10. Arch Dermatol Res. 2022. PMID: 33973061
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group. Mahil SK, et al. J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16. J Allergy Clin Immunol. 2021. PMID: 33075408 Free PMC article. Clinical Trial.
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.
Rivera R, Velasco M, Vidal D, Carrascosa JM, Daudén E, Vilarrasa E, Notario J, Ruíz-Villaverde R, Yanguas I, García-Latasa FJ, Ferrán M, Lázaro-Simó A, de la Cueva P, Salgado-Boquete L, Belinchón I. Rivera R, et al. Among authors: yanguas i. Dermatol Ther. 2020 Nov;33(6):e14066. doi: 10.1111/dth.14066. Epub 2020 Sep 3. Dermatol Ther. 2020. PMID: 32713119
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.
Muniesa C, Domingo-Domenech E, Fornons-Servent R, Peñate Y, Estrach MT, Ramón MD, Medina S, Flórez Á, Ortiz-Romero PL, Sánchez-Caminero MP, Torres-Navarro I, Acebo E, Yanguas I, Fernández-de-Misa R, Blanes M, Zayas A, Descalzo MA, Garcia-Doval I, Servitje O. Muniesa C, et al. Among authors: yanguas i. J Am Acad Dermatol. 2020 Nov;83(5):1535-1538. doi: 10.1016/j.jaad.2020.07.028. Epub 2020 Jul 16. J Am Acad Dermatol. 2020. PMID: 32682893 No abstract available.
30 results